Walgreen
07:37 :
Walgreen same-store sales dip 6.4%, miss the mark -
NEW YORK (MarketWatch) -- Walgreen Co. said Thursday its April same-store sales fell 6.4%, below the estimate for a loss of 5.1% in a survey of analysts by Thomson Reuters. Total April sales fell 3.7% to $5.8 billion. Market Pulse Stories ...
07:30 :
Walgreen same-store sales rise 1.2% -
NEW YORK (MarketWatch) -- Walgreen Co. said on Wednesday that its March same-store sales rose 1.2%. Total sales for March fell 4.3% from a year ago, to$6.02 billion. The firm said its pharmacy sales fell 8.4%, while same-store pharmacy ...
09:36 :
Retail Earnings: Best Buy, Walgreen -
Best Buy (BBY) announced that it earned $2.47 per share during is fiscal fourth quarter, exceeding analyst estimates of $2.15 per share. The company projected full year earnings of $3.50 to $3.80 per share, while analysts expected $3.70 ...
14:21 :
Forbes Earnings Preview: Walgreen -
In spite of an expected dip in profit, most analysts are positive about Walgreen (WAG) before it reports its second quarter earnings on Tuesday, March 27, 2012.
12:52 :
S&P Capital IQ cuts Walgreen to hold from buy -
CHICAGO (MarketWatch) -- S&P Capital IQ analyst Joseph Agnese downgraded retailer Walgreen Co. to hold from buy Friday, citing valuation concerns. The stock is getting close to his 12-month price target of $36. Agnese also cut his 2012 ...
08:44 :
Walgreen January same-store sales down 4.6% -
NEW YORK (MarketWatch) -- Walgreen Co. said Friday its January same-store sales fell 4.6%. The company's comparable pharmacy sales dropped 7.9%, including negative impacts from generic drug introductions and other factors, including a ...
14:40 :
Express Scripts Dragging On Walgreen Stock -
Walgreen is trying to minimize the impact of Express Scripts’ lost business through cutting costs and it expects to offset around 50% of gross profit reduction in fiscal 2012 (ending August 2012).
10:27 :
Lawsuit Says Walgreen, Par Pharma Overcharged -
A union benefits fund filed a class-action lawsuit against Walgreen and Par Pharmaceutical, accusing the companies of engaging in "at least two widespread schemes to overcharge" for generic drugs.
actualidad Walgreen -